Science37: Using Technology To Enable Remote, Clinical Trials, with Belinda Tan
socalTECH
MAY 8, 2017
Los Angeles-based Science37 (www.science37.com) The company is backed by more than $67M in funding from such investors as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures.
133 
Let's personalize your content